chr2-201237962-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000264275.9(CASP8):​c.-27+3850A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.411 in 152,052 control chromosomes in the GnomAD database, including 13,381 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.41 ( 13381 hom., cov: 32)

Consequence

CASP8
ENST00000264275.9 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.422

Publications

20 publications found
Variant links:
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
  • autoimmune lymphoproliferative syndrome type 2B
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.479 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CASP8NM_001228.5 linkc.-27+3850A>G intron_variant Intron 2 of 9 NP_001219.2 Q14790-4
CASP8NM_001400648.1 linkc.-27+3850A>G intron_variant Intron 2 of 9 NP_001387577.1
CASP8NM_001400651.1 linkc.-27+3850A>G intron_variant Intron 2 of 9 NP_001387580.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CASP8ENST00000264275.9 linkc.-27+3850A>G intron_variant Intron 2 of 9 1 ENSP00000264275.5 Q14790-4
CASP8ENST00000392258.7 linkc.-27+3850A>G intron_variant Intron 2 of 7 1 ENSP00000376087.3 Q14790-5
CASP8ENST00000471383.5 linkn.250+3850A>G intron_variant Intron 2 of 4 1

Frequencies

GnomAD3 genomes
AF:
0.411
AC:
62508
AN:
151936
Hom.:
13382
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.334
Gnomad AMI
AF:
0.417
Gnomad AMR
AF:
0.385
Gnomad ASJ
AF:
0.388
Gnomad EAS
AF:
0.229
Gnomad SAS
AF:
0.241
Gnomad FIN
AF:
0.465
Gnomad MID
AF:
0.313
Gnomad NFE
AF:
0.483
Gnomad OTH
AF:
0.429
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.411
AC:
62511
AN:
152052
Hom.:
13381
Cov.:
32
AF XY:
0.404
AC XY:
30056
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.333
AC:
13819
AN:
41468
American (AMR)
AF:
0.384
AC:
5861
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.388
AC:
1347
AN:
3470
East Asian (EAS)
AF:
0.229
AC:
1185
AN:
5180
South Asian (SAS)
AF:
0.242
AC:
1167
AN:
4828
European-Finnish (FIN)
AF:
0.465
AC:
4910
AN:
10548
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.483
AC:
32845
AN:
67976
Other (OTH)
AF:
0.429
AC:
905
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1892
3784
5675
7567
9459
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
582
1164
1746
2328
2910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.452
Hom.:
45128
Bravo
AF:
0.405
Asia WGS
AF:
0.224
AC:
781
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.2
DANN
Benign
0.42
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3769827; hg19: chr2-202102685; API